Zacks Investment Research on MSN3h
ZBH Stock to Gain From Global Expansion Amid Difficult FX ScenarioZimmer Biomet ZBH continues to gain from procedure strength, strong execution and solid momentum in innovation. Yet the stock ...
Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...
The stock's fall snapped a four-day winning streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback